Stem cell-derived exosomes in the treatment of acute myocardial infarction in preclinical animal models: a meta-analysis of randomized controlled trials

BACKGROUND: Exosomes (EXOs) derived from stem cells have become a potential new treatment for acute myocardial infarction (AMI). However, their impact is still not fully understood. Therefore, we performed this meta-analysis to systematically review the efficacy of EXOs on AMI in preclinical animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan-li, Wang, Wan-da, Cai, Ping-yu, Zheng, Feng, Zhou, Yi-fan, Li, Mei-mei, Du, Jing-ru, Lin, Shu, Lin, Hui-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994329/
https://www.ncbi.nlm.nih.gov/pubmed/35395872
http://dx.doi.org/10.1186/s13287-022-02833-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994329/
https://www.ncbi.nlm.nih.gov/pubmed/35395872
http://dx.doi.org/10.1186/s13287-022-02833-z

Ejemplares similares